Literature DB >> 17822928

Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-beta proteins.

David R Taylor1, Nigel M Hooper.   

Abstract

The conformational conversion of the cellular form of the prion protein (PrP C) into the infectious form (PrP Sc) and the proteolytic processing of the amyloid-beta (Abeta) peptide are central pathogenetic events in the prion diseases and Alzheimer's disease, respectively. Cholesterol- and sphingolipid-rich lipid rafts have emerged as important sites for the conversion of PrP C into PrP Sc, and for the proteolytic production, degradation and aggregation of Abeta. Here, we discuss these findings and their implications for our understanding of these disease processes. In addition, the potential for rafts as sites for therapeutic intervention in prion diseases and Alzheimer's disease is considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17822928     DOI: 10.1016/j.semcdb.2007.07.008

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  15 in total

1.  Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion.

Authors:  Irfan Y Tamboli; Esther Barth; Leonie Christian; Martin Siepmann; Sathish Kumar; Sandesh Singh; Karen Tolksdorf; Michael T Heneka; Dieter Lütjohann; Patrick Wunderlich; Jochen Walter
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

2.  Therapeutic effect of CHF5074, a new γ-secretase modulator, in a mouse model of scrapie.

Authors:  Giorgio Poli; Erica Corda; Barbara Lucchini; Maria Puricelli; Piera Anna Martino; Paola Dall'ara; Gino Villetti; Silvio R Bareggi; Cristiano Corona; Elena Vallino Costassa; Paola Gazzuola; Barbara Iulini; Maria Mazza; Pierluigi Acutis; Paolo Mantegazza; Cristina Casalone; Bruno P Imbimbo
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

3.  Effect of sterol structure on ordered membrane domain (raft) stability in symmetric and asymmetric vesicles.

Authors:  Johnna Wellman St Clair; Erwin London
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-03-20       Impact factor: 3.747

4.  Doppel and PrPC co-immunoprecipitate in detergent-resistant membrane domains of epithelial FRT cells.

Authors:  Anna Caputo; Daniela Sarnataro; Vincenza Campana; Maddalena Costanzo; Alessandro Negro; M Catia Sorgato; Chiara Zurzolo
Journal:  Biochem J       Date:  2009-12-23       Impact factor: 3.857

5.  Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity.

Authors:  Anna Fernández; Laura Llacuna; José C Fernández-Checa; Anna Colell
Journal:  J Neurosci       Date:  2009-05-20       Impact factor: 6.167

6.  Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes.

Authors:  Jo V Rushworth; Nigel M Hooper
Journal:  Int J Alzheimers Dis       Date:  2010-12-27

7.  Signalosomes in the brain: relevance in the development of certain neuropathologies such as Alzheimer's disease.

Authors:  Raquel Marin
Journal:  Front Physiol       Date:  2011-06-03       Impact factor: 4.566

8.  Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain.

Authors:  Victoria Lewis; Isobel J Whitehouse; Herbert Baybutt; Jean C Manson; Steven J Collins; Nigel M Hooper
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

9.  Close association of water channel AQP1 with amyloid-beta deposition in Alzheimer disease brains.

Authors:  Tamako Misawa; Kunimasa Arima; Hidehiro Mizusawa; Jun-ichi Satoh
Journal:  Acta Neuropathol       Date:  2008-05-29       Impact factor: 17.088

Review 10.  The Cellular Prion Protein: A Player in Immunological Quiescence.

Authors:  Maren K Bakkebø; Sophie Mouillet-Richard; Arild Espenes; Wilfred Goldmann; Jörg Tatzelt; Michael A Tranulis
Journal:  Front Immunol       Date:  2015-09-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.